Duke University Medical Center Dept. of Duke Cancer Center(2)

Durham, North Carolina 27710

0 studies enrolling now · 1 studies all time

What they study most

Symptomatic Refractory Resistant Carcinoid Disease

Studies at this site

• Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease — Completed